ISAAC - International Study of Asthma and Allergies in Childhood in France ARCHIVE

Head :
Annesi-Maesano Isabella, UMRS 707 : Épidémiologie, systèmes d'information, modélisationÉpidémiologie des maladies allergiques et respiratoires EPAR

Last update : 09/05/2017 | Version : 1 | ID : 8272

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name International Study of Asthma and Allergies in Childhood in France
Sign or acronym ISAAC
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL agreement
General Aspects
Medical area Pediatrics
Study of allergies
Health determinants Genetic
Lifestyle and behavior
Pollution
Social and psychosocial factors
Keywords skin test, air pollution, child, environment, allergy
Scientific investigator(s) (Contact)
Name of the director Annesi-Maesano
Surname Isabella
Address 27, rue de Chaligny 75012 Paris
Phone +33 (0)1 44 73 84 49
Email annesi@u707.jussieu.fr
Unit UMRS 707 : Épidémiologie, systèmes d'information, modélisationÉpidémiologie des maladies allergiques et respiratoires EPAR
Organization Institut national de la santé et de la recherche médicale -
Collaborations
Participation in projects, networks and consortia Yes
Details During ECHRS paediatrics. The project involves six hospital departments (Clermont-Ferrand, Marseille, Bordeaux, Reims, Strasbourg, Paris) and three specialist teams: • epidemiology team: Dr I. Annesi-Maesano, G. Debotte, INSERM U 472), • paediatric team: Prof. P. Scheinman, Dr. C. Karila, Dr. E. Paty (Necker-Enfants Malades Hospital, Paris); • metrology team: M. Squinazi, Y. Le Moullec, M. Laurent (laboratoire d’hygiène de la ville de Paris [The City of Paris Hygiene Laboratory]).
Funding
Funding status Public
Details - National Institute for Healthcare and Medical Research - Ministry of Employment and Solidarity - Mutuelle Générale de l’Éducation Nationale - Agency for the Environment and Energy Management, ADEME/PRIMEQUAL 96
Governance of the database
Sponsor(s) or organisation(s) responsible Institut national de la santé et de la recherche médicale - Inserm
Organisation status Public
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Not-repeated cross-sectional studies (except case control studies)
Database recruitment is carried out by an intermediary A population file
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Sample of children with average age of 10.4 (plus or minus standard deviation), plus or minus 0.7 years, from 108 schools and 401 classes.
Database objective
Main objective To establish a global map of the prevalence of childhood allergic diseases and to determine the risk factors for these diseases by comparing contrasting population groups based on a particularly strong or weak prevalence.

The ISAAC study consists of three phases:
The objective of Phase I is to assess the prevalence of asthma, allergic rhinitis and eczema by using a simple questionnaire and possible video questionnaire (for asthma), in representative samples of children from two age groups: 13-14 years old (obligatory for all centres) and 6-7 years old (optional).
Phase II aims to identify the risk factors and treatment procedures for allergic diseases through a more detailed study of selected population groups with relatively high or low prevalence rates suggested during Phase I.
Phase III aims to assess the trends in allergy prevalence.
As such, the Phase I protocol will be repeated in areas that participated in this phase.
Inclusion criteria - primary school children
- between 8 and 13 years old
Population type
Age Childhood (6 to 13 years)
Population covered General population
Gender Male
Woman
Geography area International
Detail of the geography area One hundred and fifty-six centres in 56 countries: North America, Central America, South America, Western Europe, Central Europe (Albania, Germany, Estonia, Spain, France, Greece, Iceland, Italy, Norway, Netherlands , Portugal, U.K., Sweden), the Baltic States, Far East, Western Pacific, Anglophone Africa, Francophone Africa, Southeast Asia, East Mediterranean countries and Oceania. In France (primary schools in six French cities: Créteil, Clermont-Ferrand, Bordeaux, Marseille, Reims, Strasbourg).
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 03/1999
Date of last collection (YYYY or MM/YYYY) 10/2000
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals Monde/World: 721 601 France: 7 432
Data
Database activity Data collection completed
Type of data collected Clinical data
Declarative data
Paraclinical data
Biological data
Clinical data (detail) Medical registration
Details of collected clinical data Allergy assessment: skin prick tests, Williams standardised skin test (eczema), free running test, with peak respiratory flow (bronchial hyper-reactivity).
Declarative data (detail) Paper self-questionnaire
Details of collected declarative data Parent questionnaire assessing the child's personal and family history, respiratory symptoms and domestic environment (allergen exposure, passive smoking, psychosocial factors)
Paraclinical data (detail) Anthropometric measurements (height, weight, hip contour , head circumference)
Biological data (detail) urine and hair cotinine research (nicotine metabolite), inflammation and lead markers
Presence of a biobank No
Health parameters studied Health event/morbidity
Procedures
Data collection method Pollutants measured in school yards and measurements collected by urban air quality monitoring networks: - SO2, FN, NOx, NO2, O3 and PM using collective measurements (city monitoring networks) (macroenvironment); - NOx, NO2, O3, VOC (formaldehyde) and PM using passive sensors within schools (microenvironment); - NO2, O3, COV. using individual badges as part of the panel (individual). Each centre can choose the protocol best suited to them. However, a minimum protocol was agreed at European level.
Participant monitoring No
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://erj.ersjournals.com/content/24/3/406.long
Link to the document http://www.sciencedirect.com/science/article/pii/S0335745708001342
Link to the document http://www.annallergy.org/article/S1081-1206%2810%2960598-4/abstract
Link to the document http://www.resmedjournal.com/article/S0954-6111%2807%2900099-6/abstract
Link to the document http://www.resmedjournal.com/article/S0954-6111%2806%2900221-6/abstract
Link to the document http://www.sciencedirect.com/science/article/pii/S1352231005010575
Link to the document http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2005.02336.x/abstract;jsessionid
Link to the document http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2005.00860.x/abstract
Link to the document http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2222.2004.02002.x/abstract
Access
Terms of data access (charter for data provision, format of data, availability delay) Contact the scientist in charge
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05